Peer-reviewedCC BYPharmaceuticals (Basel, Switzerland)
Formulation Development and Characterization of Quercetin Solid Dispersions with Integrated In Vitro Release and In Vivo Pharmacokinetic Assessment
- 1School of Pharmacy, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), , Hangzhou 311399, China
- 2Key Laboratory of Applied Technology on Green-Healthy Animal Husbandry of Zhejiang Province, Zhejiang Provincial Engineering Laboratory for Animal Health Inspection & Internet Technology, College of Animal Science and Technology & College of Veterinary Medicine, , Hangzhou 311300, China
Related
- Integrated metabolomic characterization of refrigerated storage stability and aroma development in a Lactiplantibacillus plantarum LP-315–fermented milk beverage
- Improved Dissolution Performance of Fenoprofen Calcium Using PEG 6000 Solid Dispersions: Preparation by Fusion Method and Physicochemical Characterization
- Integrated metabolomic characterization of refrigerated storage stability and aroma development in a
- Linking formulation composition to pharmacokinetic and pharmacodynamic responses: a predictive framework for sustained-release tablets
- Integrated Structural, Physicochemical, Pharmacokinetic and Pharmacodynamic Evaluation of Substituted Phenylcarbonyloxypiperazinopropanols as Antimycobacterial Agents
BibTeX
@article{guo2026formulation,
title = {{Formulation Development and Characterization of Quercetin Solid Dispersions with Integrated In Vitro Release and In Vivo Pharmacokinetic Assessment}},
author = {Zi-Xuan Guo and Zi-Yang Li and Xia-Li Wei and Xin-Yu Ji and Ting-Ting Lian and Fei Zhu and Qing-Ri Jin},
journal = {Pharmaceuticals (Basel, Switzerland)},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13708282},
note = {CC BY},
}
RIS
TY - JOUR
TI - Formulation Development and Characterization of Quercetin Solid Dispersions with Integrated In Vitro Release and In Vivo Pharmacokinetic Assessment
AU - Zi-Xuan Guo
AU - Zi-Yang Li
AU - Xia-Li Wei
AU - Xin-Yu Ji
AU - Ting-Ting Lian
AU - Fei Zhu
AU - Qing-Ri Jin
PY - 2026
DA - 2026/10/01
JO - Pharmaceuticals (Basel, Switzerland)
UR - https://europepmc.org/article/PMC/PMC13708282
SN - 1424-8247
ER -